Following 16 h treatment, NR-V04 induced a dose-dependent decrease of NR4A1 protein in CHL-1 cells with a 50% degradation concentration (DC50) of 228.5 nM and in A375 melanoma cells with DC50 of 518.8 nM (Fig. 4 A). The gene discussed is NR4A1; the disease is melanoma.